Literature DB >> 1414533

Interventional neuroradiology for the treatment of inaccessible arterio-venous malformations.

A Benati1.   

Abstract

Embolization of cerebral arterio-venous malformations (AVM) has been performed at the Department of Neuroradiology of Verona in 136 patients with a total of 310 procedures. The complication rate was 16%. In most of the cases embolization was followed by either operative removal of the AVM or by radiosurgery. In a group of 38 embolized patients, who refused operation or radiosurgery, rebleeding occurred 7 times (18%), but only in patients who already had bleedings before embolization. Indications and techniques of embolization are described and discussed.

Entities:  

Mesh:

Year:  1992        PMID: 1414533     DOI: 10.1007/bf01400728

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  10 in total

1.  The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment.

Authors:  S L Ondra; H Troupp; E D George; K Schwab
Journal:  J Neurosurg       Date:  1990-09       Impact factor: 5.115

2.  Correlation of motor cortex brain mapping data with magnetic resonance imaging.

Authors:  M S Berger; W A Cohen; G A Ojemann
Journal:  J Neurosurg       Date:  1990-03       Impact factor: 5.115

3.  Central sulcus patterns at MRI.

Authors:  O Missir; C Dutheil-Desclercs; J F Meder; A Musolino; D Fredy
Journal:  J Neuroradiol       Date:  1989       Impact factor: 3.447

4.  Surgery of arteriovenous malformations in the speech and motor-sensory regions.

Authors:  Z Kunc
Journal:  J Neurosurg       Date:  1974-03       Impact factor: 5.115

5.  Natural course of unoperated intracranial arteriovenous malformations: study of 50 cases.

Authors:  Y Itoyama; S Uemura; Y Ushio; J Kuratsu; N Nonaka; H Wada; Y Sano; A Fukumura; K Yoshida; T Yano
Journal:  J Neurosurg       Date:  1989-12       Impact factor: 5.115

6.  Preoperative embolization of arteriovenous malformations with polylene threads: techniques with wing microcatheter and pathologic results.

Authors:  A Benati; A Beltramello; R Colombari; A Maschio; S Perini; R Da Pian; A Pasqualin; R Scienza; L Rosta; E Piovan
Journal:  AJNR Am J Neuroradiol       Date:  1989 May-Jun       Impact factor: 3.825

7.  Classification of supratentorial arteriovenous malformations. A score system for evaluation of operability and surgical strategy based on an analysis of 66 cases.

Authors:  B Pertuiset; D Ancri; Y Kinuta; T Haisa; L Bordi; C Lin; M Mahdi; F Arthuis
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

8.  Cerebral arteriovenous malformations. Indications for and results of surgery, and the role of intravascular techniques.

Authors:  A J Luessenhop; L Rosa
Journal:  J Neurosurg       Date:  1984-01       Impact factor: 5.115

9.  Direct approach to arteriovenous malformations in functional areas of the cerebral hemisphere.

Authors:  S Yamada; F S Brauer; D S Knierim
Journal:  J Neurosurg       Date:  1990-03       Impact factor: 5.115

10.  Stenosis of afferent vessels of intracranial arteriovenous malformations.

Authors:  M F Omojola; A J Fox; F Viñuela; G Debrun
Journal:  AJNR Am J Neuroradiol       Date:  1985 Sep-Oct       Impact factor: 3.825

  10 in total
  3 in total

1.  Endovascular embolization with radiopaque silk threads: a feasibility study in Swine.

Authors:  G Guglielmi; A Benati; S Perini
Journal:  Interv Neuroradiol       Date:  2006-07-31       Impact factor: 1.610

2.  Palliative embolisation of brain arteriovenous malformations presenting with progressive neurological deficit.

Authors:  M Al-Yamany; K G Terbrugge; R Willinsky; W Montanera; M Tymianski; M C Wallace
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

Review 3.  The combined management of cerebral arteriovenous malformations. Experience with 100 cases and review of the literature.

Authors:  R Deruty; I Pelissou-Guyotat; C Mottolese; Y Bascoulergue; D Amat
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.